Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=134"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=134

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00240331-2d246db1",
        "title": "Rosuvastatin 10mg vs Placebo: Number of Randomised Participants That Experienced a Coronary or Peripheral Revascularisation (Including Above Ankle Limb Amputations).",
        "summary": "148 of 1389 against 152 of 1384; risk difference -0.3 points, 95% interval -2.6 to 2.0; NCT00240331, AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)",
        "record": "/library/comparisons/NCT00240331-2d246db1",
        "nct_id": "NCT00240331",
        "kind": "outcome",
        "participants": 2773,
        "risk_difference": {
          "value": -0.0032751137134462843,
          "lower": -0.026474561762158233,
          "upper": 0.019908677878559895
        },
        "group_1": "148 of 1,389",
        "group_2": "152 of 1,384",
        "difference": "-0.3 points",
        "interval": "-2.6 to 2.0",
        "trial_title": "AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)"
      },
      {
        "id": "NCT00240331-504f373e",
        "title": "Rosuvastatin 10mg vs Placebo: Number of Randomised Participants With an Atherosclerotic Cardiac Event (Non-fatal Myocardial Infarction or Coronary Heart Disease (CHD) Death)",
        "summary": "258 of 1389 against 256 of 1384; risk difference 0.1 points, 95% interval -2.8 to 3.0; NCT00240331, AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)",
        "record": "/library/comparisons/NCT00240331-504f373e",
        "nct_id": "NCT00240331",
        "kind": "outcome",
        "participants": 2773,
        "risk_difference": {
          "value": 0.0007740421228729644,
          "lower": -0.028168342115687812,
          "upper": 0.02970874663513281
        },
        "group_1": "258 of 1,389",
        "group_2": "256 of 1,384",
        "difference": "0.1 points",
        "interval": "-2.8 to 3.0",
        "trial_title": "AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=135",
  "request_id": "KbhsiX0-rYU22oIX"
}